Ono Pharmaceutical Co Ltd

Common Name

Ono Pharmaceutical

Country

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

4,287

Ticker

4528

Exchange

TOKYO STOCK EXCHANGE

Website

www.ono-pharma.com

Description

Ono Pharmaceutical Co., Ltd. is a renowned pharmaceutical company based in Japan, primarily engaged in the creation and distribution of medicinal products. The company's core mission is to develop inn... Show more

Financial Statements of Ono Pharmaceutical

Below are the financial statements of Ono Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of JPY	2024	2023
Current assets	—	—
Cash and cash equivalents	166.14^a	96.14^a
Trade and other receivables	136.07^a	114.4^a
Marketable securities	0^a	0.02^a
Other financial assets	38.45^a	68.13^a
Inventories	48.63^a	44.81^a
Other current assets	24.31^a	21.6^a
Total current assets	413.6^a	345.1^a
Non-current assets	—	—
Property, plant, and equipment	104.75^a	108.42^a
Intangible assets	57.29^a	69.13^a
Investment securities	121.15^a	123.31^a
Investments in associates	0.12^a	0.12^a
Other financial assets	173.11^a	197.44^a
Deferred tax assets	40.86^a	35.6^a
Other non-current assets	2.8^a	3.31^a
Total non-current assets	500.07^a	537.34^a
Total assets	913.67^a	882.44^a
Current liabilities	—	—
Trade and other payables	60.69^a	66.79^a
Lease liabilities	2.31^a	2.49^a
Other financial liabilities	2.27^a	0.66^a
Income taxes payable	22.09^a	34.58^a
Other current liabilities	16.26^a	18.41^a
Total current liabilities	103.62^a	122.93^a
Non-current liabilities	—	—
Lease liabilities	6.55^a	6.68^a
Other financial liabilities	0^a	0^a
Retirement benefit liabilities	3.29^a	3.35^a
Deferred tax liabilities	1.01^a	0.98^a
Other non-current liabilities	0.58^a	0.68^a
Total non-current liabilities	11.44^a	11.7^a
Total liabilities	115.06^a	134.63^a
Equity	—	—
Share capital	17.36^a	17.36^a
Capital reserves	17.46^a	17.08^a
Treasury shares	-63.23^a	-54.16^a
Other components of equity	53.19^a	51.7^a
Retained earnings	768.18^a	709.89^a
Equity attributable to owners of the parent company	792.96^a	741.87^a
Non-controlling interests	5.64^a	5.94^a
Total equity	798.6^a	747.81^a
Total liabilities and equity	913.67^a	882.44^a

Verified Sources Behind Ono Pharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ono Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Ono Pharmaceutical's Integrated Report 2024

Trace every data point back to Ono Pharmaceutical’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Ono Pharmaceutical Co Ltd

Financial Statements of Ono Pharmaceutical

Verified Sources Behind Ono Pharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Kyowa Kirin Co Ltd

Daiichi Sankyo Co Ltd

Astellas Pharma Inc

Chugai Pharmaceutical Co Ltd

Cosmos Pharmaceutical Corp

Shionogi & Co Ltd